The role of gut microbiota in osteoporosis: underlying mechanisms, clinical associations, and emerging biomaterials - Scorecard - MDSpire

The role of gut microbiota in osteoporosis: underlying mechanisms, clinical associations, and emerging biomaterials

  • By

  • Peng Ha

  • Ziying Wang

  • Guanlin Huo

  • Xiaomin Sun

  • Keqiang Yu

  • May 20, 2026

  • 0 min

Share

Clinical Scorecard: The Impact of Gut Microbiome on Osteoporosis: Mechanisms, Clinical Links, and New Biomaterial Developments

At a Glance

CategoryDetail
Condition
Key MechanismsGut microbiota regulates bone homeostasis through microbial metabolite production (e.g., short-chain fatty acids), osteoimmune balance modulation, and regulation of nutrient absorption.
Target Population
Care Setting

Key Highlights

  • Clinical translation of gut microbiota-modulating therapies faces significant challenges due to individual microbial heterogeneity and biocompatibility risks.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider pharmacological options including bisphosphonates, denosumab, and their mechanisms of action.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Older adults, particularly women post-menopause.

        Current therapies are limited by adherence issues and adverse effects.

        Clinical Best Practices

        • Integrate gut microbiome considerations into osteoporosis treatment strategies, focusing on personalized approaches.

        Related Resources & Content

        Original Source(s)

        Related Content